SCHEMBL3023947

SCHEMBL3023947

CC(C)(C)c1cc(C(C(=O)O)(C(=O)O)C(C)(C)C)c(F)c(Oc2cccc3ccccc23)c1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX5 P09917 2/20 0.38
PTGES O14684 2/20 0.38
MAPT P10636 2/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
PIN1 Q13526 1/20 0.36
NCEH1 Q6PIU2 1/20 0.35
CHEK1 O14757 1/20 0.35
ESRRA P11474 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SCN9A Q15858 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3036535 0.85 ALDH1A1 (0.37) ALDH1A1KDM4EALOX5MAPTLMNA
SCHEMBL2434985 0.78 FEN1 (0.40) ALDH1A1MAPTLMNAHTTMEN1
SCHEMBL3031367 0.71 CYP3A4 (0.35) CYP3A4
SCHEMBL3023944 0.69 PIN1 (0.40) ALDH1A1KDM4EHSD17B10ALOX5PTGES
SCHEMBL28151906 0.68 ALDH1A1 (0.48) ALDH1A1KDM4EALOX5PTGESMAPT
SCHEMBL3027901 0.64 PIN1 (0.50) ALDH1A1KDM4EHSD17B10ALOX5PTGES
SCHEMBL3033563 0.64 TDP1 (0.44) ALDH1A1KDM4EALOX5PTGESMAPT
SCHEMBL3023941 0.64 PIN1 (0.41) ALDH1A1KDM4EHSD17B10ALOX5PTGES
SCHEMBL3035330 0.64 ALDH1A1 (0.51) ALDH1A1KDM4EALOX5PTGESMAPT
SCHEMBL10422427 0.63 ALDH1A1 (0.68) ALDH1A1KDM4EALOX5PTGESMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 ALDH1A1 348/4885KDM4E 1070/4885HSD17B10 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.